Skip to content

Effects of Vitamin A Supplementation on Intestinal Parasitic Reinfections

Effects of Vitamin A Supplementation on Intestinal Parasitic Reinfections, Growth, Iron Status and Educational Achievement Among Orang Asli Schoolchildren in Pos Betau, Pahang, Malaysia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00936091
Enrollment
250
Registered
2009-07-09
Start date
2007-05-31
Completion date
2008-08-31
Last updated
2009-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Intestinal Parasitic Infections, Malnutrition

Keywords

intestinal parasitic infections, malnutrition, Anemia

Brief summary

Intestinal parasitic infections, malnutrition and iron deficiency anaemia (IDA) are still considered as public health problems in rural Malaysia especially among Orang Asli children. Despite intermittent control programmes, the prevalence of these problems is still high suggesting the need of other control and interventions measures. This randomized double-blind, placebo-controlled trial was carried out among Orang Asli schoolchildren from Sekolah Kebangsaan Betau in Pos Betau, Pahang (200 km northeast Kuala Lumpur) to investigate the effects of vitamin A supplementation on intestinal parasitic reinfections, growth, iron status and educational achievement. HYPOTHESES 1. Vitamin A supplementation has a negative effect on intestinal parasitic reinfections and the worm burden of infections among Orang Asli schoolchildren in Pos Betau, Kuala Lipis, Pahang. 2. Vitamin A supplementation has a positive effect on growth (weight and height) among Orang Asli schoolchildren. 3. Vitamin A supplementation is effective in improving serum iron status among Orang Asli schoolchildren. 4. Vitamin A supplementation has a positive effect on cognitive function and educational achievement among Orang Asli schoolchildren.

Detailed description

Children from Sekolah Kebangsaan Betau in Pos Betau, Kuala Lipis, Pahang served as the target population for this study. The selection criteria for study subjects were the following: * Age 7-12 years (according to birth date in birth certificate). * Non-menstruating females (age \<13) * No history or evidence of underlying haematological-related diseases such as thalassaemia and ovalocytosis. * No evidence of concomitant severe and/or chronic illness such as acute respiratory tract infections, mental retardation and neurological deficits. * Consent of parent to participate in the study.

Interventions

gelatinous and reddish opaque capsules containing 200 000 IU vitamin A

DRUGPlacebo

125 children received placebo capsules

Sponsors

University of Malaya
CollaboratorOTHER
Ministry of Health, Malaysia
CollaboratorOTHER_GOV
Sana'a University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
7 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 7-12 years (according to birth date in birth certificate). * No evidence of concomitant severe and/or chronic illness such as acute respiratory tract infections, mental retardation and neurological deficits. * Consent of parent to participate in the study.

Exclusion criteria

* history or evidence of underlying haematological-related diseases such as thalassaemia and ovalocytosis. * menstruating females (age \>13)

Design outcomes

Primary

MeasureTime frame
intestinal parasitic infections6 months

Secondary

MeasureTime frame
growth , iron status & educational achievement6 months

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026